Methuselah Foundation Announces $1 Million "New Organ Liver Prize" at World Stem Cell Summit
05 déc. 2013 11h47 HE
|
Genetics Policy Institute
SAN DIEGO, Dec. 5, 2013 (GLOBE NEWSWIRE) -- Methuselah Foundation, a medical charity based in Springfield, VA, announced today at the World Stem Cell Summit in San Diego the official launch of the $1...
New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products
24 nov. 2013 19h16 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a...
MEDIA ADVISORY | 2013 World Stem Cell Summit in San Diego, California, December 3-6
21 nov. 2013 02h05 HE
|
Genetics Policy Institute
SAN DIEGO, Nov. 21, 2013 (GLOBE NEWSWIRE) -- MEDIA ADVISORY
Press Opportunity to Cover International Stem Cell Community
2013 World Stem Cell Summit in San Diego, California, December 3-6
Dates:...
Hanover Portfolio Acquisitions Acquires Biotechnology Company Using Time-Varying Electromagnetic Frequencies for Regenerative Medicine
20 nov. 2013 06h00 HE
|
Hanover Portfolio Acquisitions
LOS ANGELES, CA--(Marketwired - Nov 20, 2013) - Hanover Portfolio Acquisitions (OTCQB: HVPA), an intellectual property acquisition, development and commercialization firm, announced today that it...
Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
18 nov. 2013 18h14 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...
Mesoblast's Mesenchymal Precursor Cells Induce Functional Recovery in Ischemic Stroke Model
11 nov. 2013 06h00 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced positive preclinical trial results which...
MESOBLAST UPDATES MARKET ON REGISTRATION PLANS FOR GVHD CELL PRODUCT IN JAPAN
28 oct. 2013 01h11 HE
|
Mesoblast
MELBOURNE, Australia and NEW YORK, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today updated the market on product registration plans in...
World Stem Cell Summit Poster Forum Prizes Sponsored by Stemedica
10 oct. 2013 09h38 HE
|
Genetics Policy Institute
SAN DIEGO, CALIF., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and Stemedica Cell Technologies, Inc., a leader in adult allogeneic...
San Antonio to Host 2014 World Stem Cell Summit
18 sept. 2013 17h04 HE
|
Genetics Policy Institute
SAN ANTONIO, Texas, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI), the producer of the annual World Stem Cell Summit, is announcing tonight at BioMed SA's 8th Annual Julio Palmaz...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on International Stem Cell Corporation
06 août 2013 08h30 HE
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Aug 6, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on International Stem Cell...